Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Hoff, Mari ^a,b   Kvien, Tore K ^c   Kälvesten, Johan ^d   Elden, Aake ^e   Kavanaugh, Arthur ^f   Haugeberg, Glenn ^b,g  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Sectra Imtec   (Sweden)

^e ABBOTT LABORATORIES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SØRLANDET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; METHOTREXATE; PLACEBO; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE RADIOGRAPHY; DIGITAL X RAY RADIOGRAMMETRY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HAND BONE; HUMAN; MALE; METACARPAL CORTICAL INDEX; MONOTHERAPY; MULTICENTER STUDY; OSTEOLYSIS; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG COMBINATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE RESORPTION; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HAND BONES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79951952034     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-54     Document Type: Article

References (19)

1. Osteoclasts and arthritis. G Schett SL Teitelbaum, J Bone Miner Res 2009 24 1142 1146 10.1359/jbmr.090533
2. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. PE Lipsky DM van der Heijde EW St Clair DE Furst FC Breedveld JR Kalden,, et al. N Engl J Med 2000 343 1594 1602 10.1056/NEJM200011303432202 11096166
3. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. EC Keystone AF Kavanaugh JT Sharp H Tannenbaum Y Hua LS Teoh,, et al. Arthritis Rheum 2004 50 1400 1411 10.1002/art.20217 15146409 (Pubitemid 38608061)
4. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. EW St Clair DM van der Heijde JS Smolen RN Maini JM Bathon P Emery,, et al. Arthritis Rheum 2004 50 3432 3443 10.1002/art.20568 15529377 (Pubitemid 39488667)
5. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. M Guler-Yuksel CF Allaart YP Goekoop-Ruiterman JK de Vries-Bouwstra JH van Groenendael C Mallee,, et al. Ann Rheum Dis 2009 68 330 336 10.1136/ard.2007.086348 18375540
6. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. M Hoff TK Kvien J Kalvesten A Elden G Haugeberg, Ann Rheum Dis 2009 68 1171 1176 10.1136/ard.2008.091264 18801760
7. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. P Emery MC Genovese R van Vollenhoven JT Sharp K Patra EH Sasso, J Rheumatol 2009 36 1429 1441 10.3899/jrheum.081018 19369462
8. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. JS Smolen C Han DM van der Heijde P Emery JM Bathon E Keystone,, et al. Ann Rheum Dis 2009 68 823 827 10.1136/ard.2008.090019 18593759
9. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. FC Breedveld MH Weisman AF Kavanaugh SB Cohen K Pavelka R van Vollenhoven,, et al. Arthritis Rheum 2006 54 26 37 10.1002/art.21519 16385520 (Pubitemid 43122183)
10. Metacarpal index by digital X-ray radiogrammetry: normative reference values and comparison with dual X-ray absorptiometry. L Hyldstrup SP Nielsen, J Clin Densitom 2001 4 299 306 10.1385/JCD:4:4:299 11748334 (Pubitemid 34073199)
11. The metacarpal index revisited: a brief overview. SP Nielsen, J Clin Densitom 2001 4 199 207 10.1385/JCD:4:3:199 11740061 (Pubitemid 32938086)
12. Estimation of bone mineral density by digital X-ray radiogrammetry: theoretical background and clinical testing. A Rosholm L Hyldstrup L Backsgaard M Grunkin HH Thodberg, Osteoporos Int 2001 12 961 969 10.1007/s001980170026 11804024 (Pubitemid 34001011)
13. Short time precision assessed with digital X-ray radiogrammetry in healthy individuals and rheumatoid arthritis patients. M Hoff A Dhainaut TK Kvien G Haugeberg, Annals of the rheumatic diseases 2008 67 suppl 2 563 Abstract 18042642
14. Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss. M Hoff G Haugeberg TK Kvien, Arthritis Res Ther 2007 9 81 10.1186/ar2280 17705865
15. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. ML Prevoo MA van 't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel, Arthritis Rheum 1995 38 44 48 10.1002/art.1780380107 7818570
16. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. AM van Gestel JJ Anderson PL van Riel M Boers CJ Haagsma B Rich,, et al. J Rheumatol 1999 26 705 711 10090187 (Pubitemid 29125596)
17. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum, J Clin Invest 2000 106 1481 1488 10.1172/JCI11176 11120755 (Pubitemid 32038586)
18. The Dunlop-Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. P Emery, J Rheumatol 1997 24 1436 1442 9228150 (Pubitemid 27353394)
19. Response of cortical bone to antiresorptive treatment. L Hyldstrup JT Jorgensen TK Sorensen L Baeksgaard, Calcif Tissue Int 2001 68 135 139 10.1007/s002230001204 11351495 (Pubitemid 32374472)